Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00499863 · ClinicalTrials.gov registry record · Phase 3
Evaluate the Efficacy &Safety of Methylphenidate Transdermal System (MTS) in Adolescents Aged 13-17 Years With ADHD
A Phase 3 study of ADHD, sponsored by Noven Therapeutics.
- Completed
- Registry status
- Phase 3
- Development phase
- 217
- Enrollment target
- 20
- Study locations
NCT00499863: Completed Phase 3 study of ADHD, sponsored by Noven Therapeutics.
NCT00499863 is a Phase 3 study of ADHD that has completed, run by Noven Therapeutics. The registered enrollment target is 217 participants, above the 187-participant average among 75 other ADHD trials with a reported enrollment target (16% higher). The trial reports 20 study locations across 14 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00499863, a Phase 3 study of ADHD, has completed, sponsored by Noven Therapeutics.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 217 participants
- Enrollment target
- 20
- Study locations
Study Summary
To assess the efficacy and safety of efficacy of MTS compared to placebo
Primary Outcome
The Attention Deficit Hyperactivity Disorder Rating Scale-fourth edition (ADHD-RS-IV) consists of 18 items scored on a 4-point scale ranging from 0 (no symptoms) to 3 (severe symptoms) with total score ranging from 0 to 54.
Conditions Studied
Interventions
- DRUG Placebo
- DRUG methylphenidate transdermal system
Study Locations (20)
California
- Bay Area Research Institute - Lafayette
- Elite Clinical Trials Inc. - Wildomar
Florida
- Sarkis Clinical Trials - Gainesville
- Miami Research Associates - South Miami
Kentucky
- Shire Clinical Research Site - Lexington
- Four Rivers Clinical Research, Inc. - Paducah
Michigan
- Rochester Center for Behavioral Medicine - Rochester Hills
- Clinical Neurophysiology Services, PC - Troy
North Dakota
- Dakota Clinic/Innovis health - Fargo
- Odyssey Research - Minot
Oregon
- Oregon Center for Clinical Investigations, Inc. - Eugene
- OCCI, Inc - Portland
Arizona
- Melmed Center - Scottsdale
Georgia
- Northwest Behavioral Research Ctr - Roswell
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 217 participants |
| Start Date | 2007-07 |
| Est. Completion | 2008-05 |
| Phase | Phase 3 |
What the finished NCT00499863 record still lists
NCT00499863 is an interventional study that assigns participants to a tested intervention. The registered 217 participants enrollment target is mid-sized for trials with a published cap, above the 187-participant average among 75 other ADHD trials with a reported enrollment target (16% higher).
The record links to 1 condition, with ADHD appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT00499863 names 20 study sites across 14 states, led by California, Florida, Kentucky.
Frequently Asked Questions
What is clinical trial NCT00499863 about?
NCT00499863 is a clinical study titled "Evaluate the Efficacy &Safety of Methylphenidate Transdermal System (MTS) in Adolescents Aged 13-17 Years With ADHD". To assess the efficacy and safety of efficacy of MTS compared to placebo
What is the current status of trial NCT00499863?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 217 participants. The study started on 2007-07. Estimated completion is 2008-05.
What conditions does trial NCT00499863 study?
This clinical trial studies the following conditions: ADHD.
What interventions are being tested in trial NCT00499863?
The interventions under investigation include: Placebo (DRUG), methylphenidate transdermal system (DRUG).
Who is sponsoring clinical trial NCT00499863?
This trial is sponsored by Noven Therapeutics, which has 10 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00499863 being conducted?
This trial has 20 study locations across Arizona, California, Florida, Georgia, Idaho. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for ADHD
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00499863's enrollment target sits among peer trials
217 20th of 75 higher than 56 of 75 other ADHD trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other ADHD trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
P3b Short-term Study of CTN in Patients With ADHD and Comorbid Anxiety
RECRUITING · Phase 3
-
Treating Parents with ADHD and Their Young Children Via Telehealth: a Hybrid Type I Effectiveness-Implementation Trial
ACTIVE NOT RECRUITING · Phase 3
-
Smoking Cessation for Adults With Attention Deficit Hyperactivity Disorder (ADHD)
COMPLETED · Phase 3
-
Safety and Efficacy Study of Dexmethylphenidate in Children With ADHD
COMPLETED · Phase 3
-
Study to Assess Satisfaction With Modafinil Treatment in Children and Adolescents With ADHD
COMPLETED · Phase 3
-
PRC-063 Adult Laboratory Classroom Study in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD)
COMPLETED · Phase 3
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05079282 · 217 participants · Phase 1
Study of ONO-4685 in Patients With Relapsed or Refractory T Cell Lymphoma
- NCT05470439 · 217 participants · NA
My Interprofessional Care Team for Adherence and Research Engagement Disparities
- NCT05981703 · 217 participants · Phase 1
A Study Investigating BGB-26808 Alone or in Combination With Tislelizumab in Participants With Advanced Solid Tumors
- NCT06342258 · 217 participants · Phase 1
COES: Curing Order Effects on Sealants
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia